DEFA14A: Rapport Therapeutics Sets Date for 2025 Annual Meeting, Outlines Proposals for Stockholder Vote

Rapport Therapeutics announces its 2025 Annual Meeting of Stockholders to be held virtually on June 17, 2025, with proposals including the election of Class I Directors and ratification of PricewaterhouseCoopers LLP as the independent accounting firm.

Summary

• Rapport Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 17, 2025, at 9:30 AM ET.
• Stockholders are invited to vote on key proposals, including the election of three Class I Directors: Reid Huber, John Maraganore, and Wendy B. Young.
• Another proposal involves ratifying the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The proxy materials, including the Notice, Proxy Statement, and 2024 Annual Report, are available online.
• Stockholders can request a free paper or email copy of these materials before June 3, 2025, via www.ProxyVote.com, by calling 1-800-579-1639, or by emailing sendmaterial@proxyvote.com.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an annual meeting and proxy voting, indicating standard corporate governance procedures. The sentiment is neutral to slightly positive as it reflects transparency and shareholder engagement.

Positives

• The company is providing multiple avenues for stockholders to access proxy materials and cast their votes, including online access, phone requests, and email options.
• The virtual format of the annual meeting allows for broader participation from stockholders.

Future Outlook

The document outlines the agenda for the upcoming annual meeting and seeks stockholder approval on key governance matters.

Industry Context

This announcement is a standard part of corporate governance, ensuring stockholders have the opportunity to vote on important company matters.

Stakeholder Impact

• Stockholders have the opportunity to influence the company's direction through their votes.
• The outcome of the votes will impact the composition of the Board of Directors and the selection of the independent accounting firm.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals before the annual meeting.
• The company will proceed with the annual meeting on June 17, 2025.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Rapport Therapeutics, Directors, PricewaterhouseCoopers, Voting